Pacira
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
2000 Sierra Point Pkwy Ste 900, Brisbane...Phone Number
(855) 793-9727Website
www.pacira.comRevenue
$734.9 MillionStock Symbol
PCRXIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
8
8
1
1
2
2
About Pacira
Pacira is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient outcomes. We have a drive and a desire to improve the world around us and make a meaningful difference in the lives of patients, families, communities, and society. (Nasdaq: PCRX) is a provider of non-opioid pain management and regenerative health solutions manufacturing.Explore more
Pacira Org Chart
Get the full picture
Sign in to uncover key details.
MH
Director, Corporate Counsel
PM
General Counsel
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pacira your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Pacira has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Pacira has new funding data
Earning: See what the market has to say on Pacira recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Pacira, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Pacira launches new products
Check out if Pacira is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Pacira
Click to see if Pacira had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Pacira
Compare insights from companies similar to Pacira, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pacira is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pacira is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pacira.
Pacira financials insights
Gather financial insights about Pacira, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Stock Offering
$42M
Pacira Tech Stack
A closer look at the technologies used by Pacira
See more technologies
Most Recent Scoops
Hiring Plans
Pacira has more open roles in Marketing than it has had at any time in the past 6 months. Areas of expertise include: Market Research.
Hiring Plans
Person-Based
Lawsuits, Legal Affairs, Finance, Investor Relations
Open Position
Open Position
Open Position
Pacira News & Media
Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees
ISS Concludes "There is a Compelling Reason to Support all Management Nominees" and Notes "the Dissident Has Not Presented a Compelling Case for Change" BRISBANE, Calif., June 1, 2026 /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader...Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
BRISBANE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company” or “Pacira”), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that leading independent proxy advisory firm Glass Lewis & Co., LLC (“Glass Lewis”) has recommended that Pacira stockholders vote “FOR” each of Pacira’s three director nominees – Christopher Christie, Samit Hirawat, MD and Thomas Wiggans – aConsidering Pacira Biosciences Inc (PCRX) Stock After Q1 Report? Check the Details
Pacira Biosciences Inc (NASDAQ:PCRX) is one of the best micro and small cap stocks to buy according to Jim Simons’ Renaissance Technologies. Analysts expect the stock to pop more than 20% from its current level. Pacira Biosciences Inc (NASDAQ:PCRX) reported its Q1 2026 results on April 30. It said revenue jumped 5% YoY to $177.4 […]Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees
Clarifies DOMA’s Inaccuracies and the Reality of Pacira’ Efforts to Strengthen its Market Position
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pacira
Sign Up For FreeTo access detailed company insights
Pacira is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient outcomes. We have a drive and a desire to improve the world around us and make a meaningful difference in the lives of patients, families, communities, and society. (Nasdaq: PCRX) is a provider of non-opioid pa... Read More
